Related Experiment Video
Updated: Jun 23, 2025

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
UBE2C orchestrates bone formation through stabilization of SMAD1/5
Hui Zhang1, Yangge Du1, Dazhuang Lu1
1Department of Prosthodontics, Peking University School and Hospital of Stomatology, 22 Zhongguancun South Avenue, Haidian District, 100081 Beijing, China; National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & National Health Commission Key Laboratory of Digital Technology of Stomatology, 22 Zhongguancun South Avenue, Haidian District, 100081 Beijing, China.
Abstract:
While previous studies have demonstrated the role of ubiquitin-conjugating enzyme 2C (UBE2C) in promoting β-cell proliferation and cancer cell lineage expansion, its specific function and mechanism in bone marrow mesenchymal stem/stromal cells (BMSCs) growth and differentiation remain poorly understood. Our findings indicate that mice with conditional Ube2c deletions in BMSCs and osteoblasts exhibit reduced skeletal bone mass and impaired bone repair. A significant reduction in the proliferative capacity of BMSCs was observed in conditional Ube2c knockout mice, with no effect on apoptosis. Additionally, conditional Ube2c knockout mice exhibited enhanced osteoclastic activity and reduced osteogenic differentiation. Furthermore, human BMSCs with stable UBE2C knockdown exhibited diminished capacity for osteogenic differentiation. Mechanistically, we discovered that UBE2C binds to and stabilizes SMAD1/5 protein expression levels. Interestingly, UBE2C's role in regulating osteogenic differentiation and SMAD1/5 expression levels appears to be independent of its enzymatic activity. Notably, UBE2C regulates osteogenic differentiation through SMAD1/5 signaling. In conclusion, our findings underscore the pivotal role of UBE2C in bone formation, emphasizing its contribution to enhanced osteogenic differentiation through the stabilization of SMAD1/5. These results propose UBE2C as a promising target for BMSC-based bone regeneration.
Insights
Ubiquitin-conjugating enzyme 2C (UBE2C) is crucial for bone marrow mesenchymal stem cell (BMSC) growth and osteogenic differentiation. UBE2C stabilizes SMAD1/5, promoting bone formation and repair, making it a target for bone regeneration therapies.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- Ubiquitin-conjugating enzyme 2C (UBE2C) is known to influence cell proliferation and cancer progression.
- The specific role of UBE2C in bone marrow mesenchymal stem/stromal cells (BMSCs) and bone metabolism is not well understood.
Purpose of the Study:
- To investigate the function and mechanism of UBE2C in BMSC growth, differentiation, and bone formation.
- To explore UBE2C's potential as a therapeutic target for bone regeneration.
Main Methods:
- Conditional Ube2c knockout mice models in BMSCs and osteoblasts.
- Assessment of skeletal bone mass and bone repair capacity.
- In vitro studies using human BMSCs with UBE2C knockdown.
- Analysis of BMSC proliferation, apoptosis, osteogenic, and osteoclastic differentiation.
- Mechanistic studies involving SMAD1/5 protein expression and signaling pathways.
Main Results:
- Conditional Ube2c deletion in mice led to reduced skeletal bone mass and impaired bone repair.
- Ube2c knockout BMSCs showed reduced proliferation but no change in apoptosis.
- Osteoclastic activity was enhanced, and osteogenic differentiation was reduced in knockout mice.
- Human BMSCs with UBE2C knockdown exhibited diminished osteogenic differentiation capacity.
- UBE2C stabilizes SMAD1/5 protein levels, regulating osteogenic differentiation independently of its enzymatic activity.
Conclusions:
- UBE2C plays a critical role in bone formation by promoting osteogenic differentiation.
- UBE2C enhances osteogenic differentiation via stabilization of SMAD1/5 signaling.
- UBE2C is a potential therapeutic target for BMSC-based bone regeneration strategies.
Related Concept Videos
Bone Formation by Endochondral Ossification
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
Bone Remodeling
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Hedgehog Signaling Pathway

